Modulating the tumor microenvironment via oncolytic virus and PI3K inhibition synergistically restores immune checkpoint therapy response in PTEN-deficient glioblastoma.
Fan XingJingshu XiaoJunyu WuJiaming LiangXiaoyu LuLiping GuoPing LiPanpan HouChunmei LiDe-Ying GuoPublished in: Signal transduction and targeted therapy (2021)